drugset / Trial / NCT00092118

The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)

NCT00092118

Phase 3 Completed 1992 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of an approved medication on the symptoms of perennial allergic rhinitis (an inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year), in patients who have a history of perennial allergic rhinitis.

Timeline

Start
2003-10
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg